Home > Cardiology > Pfizer/BioNTech vaccine safe after myocarditis

Pfizer/BioNTech vaccine safe after myocarditis

ESC Acute CardioVascular Care 2022
Reuters - 18/04/2022 - People who have had myocarditis in the past can safety receive the COVID-19 mRNA vaccine from Pfizer and BioNTech without causing the problem to recur, a small study suggests.

Myocarditis is a common complication of COVID and other viral infections and has been a rare side effect associated with some COVID-19 vaccines, primarily in young males. But among 55 patients who had recovered from myocarditis within the past five years and who later received a COVID-19 mRNA vaccine, no one suffered a repeat episode of myocarditis, researchers reported at the European heart meeting ESC Acute CardioVascular Care 2022.

Of the 55 subjects, 43 had received both doses of the vaccine and 12 just the first dose. Nearly all had received the Pfizer/BioNTech vaccine, so the findings may not apply to other shots, the researchers said.

Still, the results "provide reassuring data that may encourage patients with a history of myocarditis to get vaccinated against SARS-CoV-2," study author Dr. Iyad Abou Saleh of Hospices Civils de Lyon, France, said in a statement.

SOURCE: https://bit.ly/3xxFvCh, ESC Acute CardioVascular Care 2022, online March 18, 2022.

By Reuters Staff

Posted on